News | November 09, 2023
Biocon Biologics announces divestment of two non-core branded formulations
Total transaction value of the divestment is Rs. 3,660 million
Total transaction value of the divestment is Rs. 3,660 million
He will be responsible for leading all the activities related to the Research & Development (Formulations) Division of the company
The new gummy capabilities include a dedicated R&D lab, an automated production line, and bottle packaging solutions
At the end of the inspection, the facility received two observations, one on written production process control procedure and the other on investigation procedure
USFDA issued issued Form 483 with nine observations, which will be addressed within stipulated time.
With more than 35 years of experience, Best Formulations is the largest manufacturer of plant-based softgels in the United States, with newly expanded capabilities for nutritional gummies and personal care
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
This was a pre-approval inspection to cover our Oncology Injectable drug products for which ANDAs were filed with USFDA
This is the second line opened this year for parenteral drug product clinical and commercial manufacturing, with an annual capacity of 10 million units
The new plant will include a wide range of dosage form capabilities for oral solids, liquids, topicals, films, and manufacturing technologies for granulation, film coating, spray drying, tableting
Subscribe To Our Newsletter & Stay Updated
